iBIO NEWS
Your source for the news and events happening in our communityiBIO NEWS
COMMUNITY NEWS
iBIO January Grants Report Highlights Expansive Funding Opportunities for Life Sciences Innovation
Xentria Secures Landmark Agreement with NYU for Cardiovascular Therapy Development
Capital Pulse: Flow Medical Secures $5M Seed Round, Including First-Ever UCM Ventures Investment
The Growing Crisis of Antimicrobial Resistance: Meitheal Takes Action with XENLETA®
POLICY NEWS
FDA Announces Medicare Coverage Pathway for Breakthrough Medical Technologies: iBIO Statement
iBIO Statement on Section 232 Pharmaceutical Tariffs
Statement from John Conrad, President & CEO, Illinois Biotechnology Innovation Organization (iBIO), on Governor Pritzker’s Budget Address
Setting the Record Straight on 340B in Illinois
ALL NEWS
Statement from iBIO President & CEO John Conrad on the Resignation of FDA Commissioner Dr. Marty Makary
In response to the news of FDA Commissioner Dr. Marty Makary’s resignation, Illinois Biotechnology...
33 Semi-Finalists Compete in 15th Annual Illinois BioGENEius Competition
Thirty-three semi-finalists competed yesterday in iBIO's 15th annual Illinois BioGENEius...
Emalex Biosciences Acquired by Teva
Emalex Biosciences has been acquired by Teva Pharmaceutical Industries, marking a significant...
FDA Announces Medicare Coverage Pathway for Breakthrough Medical Technologies: iBIO Statement
Statement from John Conrad, President & CEO, iBIO “The FDA’s recent announcement advancing a...
iBIO Statement on Section 232 Pharmaceutical Tariffs
Statement from John Conrad, President & CEO, iBIO “In Illinois, we’ve seen what the right...
Best STEM Summer Camps in Chicago for Girls
We are thrilled to bring STEMgirls Camp to Chicago for the very first time! This hands-on,...
Statement from John Conrad, President & CEO, Illinois Biotechnology Innovation Organization (iBIO), on Governor Pritzker’s Budget Address
John Conrad, President and CEO of the Illinois Biotechnology Innovation Organization (iBIO),...
Illinois Life Sciences: A Moment of Momentum — and a Moment for Action
Illinois’ life sciences industry is entering one of the most promising periods in its history....
Fast Company Spotlights Chicago Startup: Dimension Bio Transforming Liver Care
It was exciting to see Dimension Bio featured in Fast Company this week — a national spotlight...
Abbott’s $21B Exact Sciences Buy Marks a Big Bet on Cancer Screening
Abbott confirmed a $21 billion deal to acquire Exact Sciences, instantly becoming one of the...